Jump to content
Search
You are not logged in |
Login
Rheumatoid Arthritis (RA)
Help for you
Support us
Campaign
About us
Join
Donate
You are here:
Home
Campaign
Media Centre
World Arthritis Day Webchat - Questions and Answers Published
Print this page
Email to friend
Email This Page To A Friend
Friends Name
Friends Email Address
Your Name
Your Email Address
Message
View our
Privacy Policy
Our latest campaigns
How can I get involved?
The Devolved Nations
How does Campaigning help you?
National conferences
Media Centre
Scottish Medicines Consortium decision on extending the use of etanercept (Enbrel®)for the treatment of active polyarticular juvenile idiopathic arthritis in NHS Scotland
Twice as likely – Coalition of charities calls for better care and support for people with long term conditions and depression
NRAS signs up to joint letter in the Guardian about the unforeseen impacts of the Legal Aid Bill
Scottish Medicines Consortium decision on extending the use of tocilizumab (RoActemra®) in NHS Scotland
Health Foundation Report: Leading the way to shared decision making
NICE have published a new quality standard and guidance on patient experience in adult NHS services
NICE Recommends RoActemra (tocilizumab) for the treatment of Rheumatoid Arthritis after failure of non-biologic DMARDs.
Care & Support Alliance: Select Committee Report Shows It’s Time For Government To Act On Social Care
BSR welcomes NICE recognition of CQRA work
NRAS supports anti ‘Bedroom Tax’ amendment in the Welfare Reform Bill
NRAS urges Government to reform the social care system
NRAS sign open letter calling for Government to clarify social care bill wording
Open letter to the Prime Minister discussing the state of social care in England.
NRAS welcomes final NICE guidance on RoActemra® (Tocilizumab) for systemic juvenile idiopathic arthritis (sJIA)
NRAS welcomes the publication of Professor Harrington’s second independent review on the Work Capability Assessment in 2011
NRAS Mark Third Healthcare Champions Award Success
World Arthritis Day Webchat - Questions and Answers Published
New RA and Physiotherapy report published by NRAS and CSP
PAUL BURSTOW MP - WORLD ARTHRITIS DAY: WEBCHAT WITH NRAS AND CSP
NRAS response to Professor Harrington’s Year 2 Review on the Work Capability Assessment
New Arthritis Research UK questionnaire on Personal Health Budgets
NRAS response to Work and Pensions Select Committee report on reassessment of incapacity benefit
Negative NICE Announcement for Abatacept
NRAS welcomes NICE guidance on Golimumab (Simponi)
DBC responds to the Personal Independence Payment (PIP) Consultation
Listen Up - Health & Social Care Bill
NICE Recommends Simponi (golimumab) for Rheumatoid Arthritis (RA)
The Budget
Open letter to the Prime Minister discussing the state of social care in England
NRAS welcomes final NICE guidance on RoActemra - widening access to Biologic Therapies in Rheumatoid Arthritis
NICE issues Final Guidance on biologic therapy options post TNF failure
NICE on Abatacept post DMARD failure
New data reveal first predictive biomarkers to tailor rheumatoid arthritis therapy
80% of rheumatoid arthritis patients in Scotland say fatigue is biggest barrier to employment
NICE Negative on Tocilizumab
Disappointment at NICE's switching decision
Media Centre archive
NICE have published a new quality standard and guidance on patient experience in adult NHS services
Family Matters Survey 2012
<a href="http://www.coveritlive.com/mobile.php/option=com_mobile/task=viewaltcast/altcast_code=b613d09b86" >Paul Burstow talks to NRAS</a>